Overview of the DNA Sequencing Market Report:
Global DNA Sequencing Market was valued at $5,156 million in 2016 and is expected to reach $18,284 million in 2023, registering a CAGR of 19.6% from 2017 to 2023. DNA sequencing is a technology in which several DNA strands could be sequenced through massive parallelization. This sequencing includes both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. Low cost, high accuracy and speed, and precise results even from low sample input are the main advantages DNA sequencing offers over microarray and other genomic analysis methods.
DNA sequencing is used to execute various applications, such as biomarker discovery, oncology studies, personalized medicine, forensics, and others. It has streamlined nucleotide analysis and consist of widely replaced conventional tools of genomics, especially microarray, genotyping, and others. The demand for DNA sequencing has increased significantly, owing to surge in sequencing applications and rise in technological advancements in DNA sequencing. In addition, the growth in number of genome mapping programs globally and increase in R&D investment drive the market growth.
DNA Sequencing Market Segmentation
The DNA sequencing market is segmented based on product, application, technology, end user, and geography. Based on product, it is classified into consumable, instrument, and service. The consumables segment occupied dominant share in 2016, and is expected to maintain this trend during the forecast period. This is attributed to the fact that they are widely used throughout the sample preparation process and are needed to perform other pre-requisite steps of DNA sequencing.
DNA Sequencing Market, By Geography, 2016-2023 ($Million)
Asia-Pacific possesses high market potential for the growth of DNA sequencing market, owing to increase in awareness about DNA sequencing, rise in DNA sequencing applications, and others. This region is anticipated to experience fast-paced growth, in terms of development and use of DNA sequencing technologies.
India DNA Sequencing Market, 2016-2023 ($Million)
The key players operating in the global DNA sequencing market include Illumina, Inc., Thermo Fisher Scientific, Inc., Siemens AG, Pacific Biosciences of California, Inc., ZS Genetics, Inc., Beckman Coulter (Fullerton, CA), 454 Life Sciences Corporation (Roche Holding AG), Agilent Technologies, Inc., Abbott Laboratories, and LI-COR, Inc.
The other prominent players in the value chain include Eurofins Scientific, Gatc Biotech AG, Macrogen, Inc., Oxford Nanopore Technologies, Ltd., Bio-Rad Laboratories, Inc., DNASTAR, Inc., Biomatters Ltd., New England Biolabs, Inc., and Myriad Genetics, Inc.
Key Benefits for Stakeholders
- The study provides an in-depth analysis of the global DNA sequencing market, with current trends and future estimations to elucidate the imminent investment pockets.
- A quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities is discussed.
- Key market players are profiled and their strategies are analyzed thoroughly, which help understand the competitive outlook of the market.
- Porter’s Five Forces model interprets the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition in the key players.
DNA Sequencing Market Key Segments:
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Other Applications
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Single Molecule Real Time Sequencing
- Chain Termination Sequencing
- Nanopore Sequencing
By End User
- Academic & Government Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Hospitals & Clinics
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA